Evidence map›Paper›PMID 40787984›Full record

ArticlemSystems2025

Hfq balances energetic efficiency and antibiotic persistence in

Abhiroop Sett, Arsalan Hussain, Srestha Tomar, Ashish Kumar Ray, Ranjana Pathania

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Redefining Antimicrobial Resistance inInternational journal of molecular sciences · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abhiroop SettDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.ORCID 0000-0002-4922-0800
Arsalan HussainDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.
Srestha TomarDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.
Ashish Kumar RayDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.
Ranjana PathaniaDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.ORCID 0000-0002-7965-8176

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR38022/MED/29/1523/2020Wellcome Trust
6 · The paper itself

Abstract

The RNA chaperone Hfq of

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial ProteinsEnergy MetabolismHost Factor 1 ProteinAcinetobacter InfectionsAnimalsCefepimeGene Expression Regulation, BacterialMiceMicrobial Sensitivity TestsVirulenceAnti-Bacterial AgentsBacterial ProteinsCefepimeHost Factor 1 ProteinAcinetobacter baumanniiin vivo antibiotic persistencepost-transcriptional regulationRNA chaperone Hfqtranscriptome

Identifiers

PMID40787984
PMCPMC12455925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.